Bectumomab
Bectumomab (IMMU-LL 2) is an humanized IgG2a mAb against human CD22 (antigen) . Bectumomab is also an anti-lymphoma antibody fragment. Bectumomab can be used for imaging in combination with technetium 99 (Tc99m LL2 Fab) . Moreover, Bectumomab examines in the staging of recurrent or newly diagnosed non-Hodgkin's lymphoma (NHL) and to assess targeting before radioimmunoresearch (RIT) [1].
Product Specifications
CAS Number
158318-63-9
Product Name Alternative
IMMU-LL 2
UNSPSC
12352203
Target
CD22
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bectumomab.html
Solubility
10 mM in DMSO
Smiles
[Bectumomab]
References & Citations
[1]Lamonica D, et al. Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL) . Cancer Biother Radiopharm. 2002 Dec;17 (6) :689-97.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A101170 100 µL
Anti-CD164 (Rabbit, Monoclonal, Rabbit/Human Fc chimeric IgG1)
Sign In for Pricing
View Details 